Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Combination therapy for maximal myocardial infarct size reduction.

S L Hale1, R A Kloner

  • 1Heart Institute of Good Samaritan Hospital, Los Angeles, CA 90017, USA. sharon.hale@attglobal.net

Heart Disease (Hagerstown, Md.)
|April 27, 2002
PubMed
Summary

Combining cariporide, regional hypothermia, and ischemic preconditioning (CHIP) significantly reduces myocardial infarct size. This combined therapy offers extraordinary protection against ischemia/reperfusion injury, even during prolonged coronary artery occlusion.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The assessment of vascular risk in men with erectile dysfunction: the role of the cardiologist and general physician.

International journal of clinical practice·2013
Same author

Emotional stressors trigger cardiovascular events.

International journal of clinical practice·2012
Same author

Incidence of diabetic retinopathy in people with type 2 diabetes mellitus attending the Diabetic Retinopathy Screening Service for Wales: retrospective analysis.

BMJ (Clinical research ed.)·2012
Same author

Bone marrow-derived cell transplantation therapy for myocardial infarction: lessons learned and future questions.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2011
Same author

The endothelial cell in health and disease: its function, dysfunction, measurement and therapy.

International journal of impotence research·2009
Same author

How to save a life during a clinic visit for erectile dysfunction by modifying cardiovascular risk factors.

International journal of impotence research·2009

Area of Science:

  • Cardiovascular Research
  • Ischemia-Reperfusion Injury
  • Cardioprotection

Background:

  • Myocardial infarct size is a critical determinant of heart failure after myocardial infarction.
  • Individual therapies like cariporide, hypothermia, and ischemic preconditioning show promise in reducing infarct size.
  • Optimizing infarct size reduction requires investigating synergistic effects of combined therapies.

Purpose of the Study:

  • To evaluate the efficacy of a combined therapy (cariporide, regional hypothermia, ischemic preconditioning - CHIP) in reducing myocardial infarct size.
  • To determine if CHIP optimizes infarct size reduction compared to individual interventions.
  • To assess the protective effects of CHIP under different durations of coronary artery occlusion.

Main Methods:

Related Experiment Videos

  • Rabbits underwent 30 or 90 minutes of coronary artery occlusion followed by reperfusion.
  • Treated groups received cariporide, ischemic preconditioning, and mild regional hypothermia (CHIP).
  • Control groups received saline and a waiting period; infarct size and risk zone were measured.

    • Main Results:

    • In the 30-minute occlusion model, CHIP reduced infarct size to 4% of the risk zone (91% reduction vs. control).
    • In the 90-minute occlusion model, CHIP reduced infarct size to 34% of the risk zone (55% reduction vs. control).
    • Risk zone size was comparable between CHIP and control groups, indicating CHIP's specific effect on infarct size.

    Conclusions:

    • The combined therapy (CHIP) provides extraordinary cardioprotection against ischemia/reperfusion injury.
    • CHIP significantly reduces myocardial infarct size, outperforming previously observed effects of single interventions.
    • This therapeutic approach holds potential for mitigating myocardial damage even in prolonged ischemic events.